Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
J Infect Dev Ctries ; 14(11): 1320-1326, 2020 11 30.
Article in English | MEDLINE | ID: mdl-33296346

ABSTRACT

INTRODUCTION: Esophageal squamous cell carcinoma (ESCC) is a dismal disease exhibiting striking geographical differences in its incidence. It is multifactorial in origin. Among infectious agents, human papillomavirus (HPV) was introduced as a possible causative agent in the development of ESCC in 1982. Subsequent studies using various methods have confirmed the presence of HPV in ESCC. We aimed to determine the frequency of HPV in ESCC in northwest Pakistan which is part of high risk belt for this disease. METHODOLOGY: This study was conducted on two hundred and forty-three (243) diagnosed cases of ESSC at two tertiary care hospitals of Peshawar, Pakistan, from 2011 to 2016. DNA was extracted from all specimens. Polymerase chain reaction (PCR) was used to check the quality of DNA using ß-globin primers and frequency and genotypes of HPV using HPV general primers and type-specific primers respectively. HPV and its genotypes were confirmed through the sequencing of a few selected cases. RESULTS: Two hundred and three (203) tissue specimens had adequate DNA and were further analyzed. HPV positivity with general primers alone was 15.7% (32/203). Using HPV general primers and type-specific primers (HPV 16 or HPV 18), the overall positivity of HPV was 31% (63/203). For type-specific primers, frequency of HPV types 16 and 18 was 20.19% (41) and 7.8% (16) respectively where 6 cases were positive for both HPV 16 and 18. CONCLUSIONS: The overall high prevalence of HPV indicates it as a possible risk factor for ESSC.


Subject(s)
Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/virology , Esophageal Squamous Cell Carcinoma/epidemiology , Esophageal Squamous Cell Carcinoma/virology , Genotype , Papillomaviridae/pathogenicity , Papillomavirus Infections/complications , DNA Primers , DNA, Viral/genetics , Humans , Incidence , Pakistan , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Paraffin Embedding , Prevalence , Qualitative Research , Tertiary Care Centers/statistics & numerical data
2.
J Cancer ; 11(23): 6768-6781, 2020.
Article in English | MEDLINE | ID: mdl-33123268

ABSTRACT

MLAA-34 is a novel leukemia-associated gene closely related to the carcinogenesis of acute monocytic leukemia (AML). MLAA-34 over expression has been observed to inhibit apoptosis in vitro. JAK2/STAT3 pathway plays an important role in cell proliferation, differentiation and inhibition of apoptosis in number of cancers. However, the relationship and interaction between MLAA-34 and JAK2/STAT3 has never been investigated in AML. This study investigates and reports a novel relationship between MLAA-34 and JAK2/STAT3 pathway in AML both in vitro and in vivo. We constructed MLAA-34 knockdown vector and transfected U937 cells to observe its apoptotic activities in relation to JAK2/STAT3 signaling pathway in vitro and then in vivo in mouse model. Levels of expression of MLAA-34 and JAK2/STAT3 and its downstream targets were also measured in AML patients and a few volunteers. We found that MLAA-34 knockdown increased U937 apoptosis in vitro and inhibited tumor growth in vivo. Components of the canonical JAK2/STAT3 pathway or its downstream targets, including c-myc, bcl-2, Bax, and caspase-3, were shown to be involved in the carcinogenesis of AML. We also found that the JAK2/STAT3 pathway positively regulated MLAA-34 expression. We additionally identified a STAT3 binding site in the MLAA-34 promoter where STAT3 binds directly and activates MLAA-34 expression. In addition, MLAA-34 was found to form a complex with JAK2 and was enhanced by JAK2 activation. Correlation of MLAA-34 and JAK2/STAT3 was further confirmed in AML patients. In conclusion, MLAA-34 is a novel regulator for JAK2/STAT3 signaling, and in turn, is regulated by this interaction in a positive feedback loop. Thus we report a novel model of interaction mechanism between MLAA-34 and JAK2/STAT3 which can be utilized as a potential target for a novel therapeutic approach in AML.

3.
Am J Clin Pathol ; 153(4): 502-512, 2020 03 09.
Article in English | MEDLINE | ID: mdl-31819948

ABSTRACT

OBJECTIVES: To evaluate the correlation between tumor-infiltrating lymphocytes (TILs) and the viral load of high-risk human papillomavirus (HR-HPV) in cervical cancer patients. METHODS: A total of 62 cervical cancer patients were recruited during 1993-1994 and assigned into four groups treated with radiotherapy alone or radiotherapy combined with chemotherapy and/or thermotherapy. Ki67+ tumor cells, CD4+, CD8+, FoxP3+, OX40+ and granzyme B+ TILs were detected by immunohistochemistry. The viral load of HR-HPV in biopsy tissues before therapy was detected by in situ hybridization. RESULTS: The patients with high HPV viral load showed a significantly lower 15-year survival rate and an advanced International Federation of Gynecology and Obstetrics (FIGO) stage and increased recurrence rate. The distribution of Ki67+ tumor cells, FoxP3+ TILs, and CD8+/FoxP3+ ratio was obviously different between low and high HPV viral load groups. A worse clinical outcome was also implicated with increased HPV viral load tested by Cox regression analysis. CONCLUSIONS: Patients with increased HR-HPV viral load tend to be resistant to therapy with decreased immune surveillance in the immune microenvironment. Thus, HR-HPV viral load would influence the local immune microenvironment, and then further affect the survival of cervical cancer patients.


Subject(s)
Carcinoma, Squamous Cell/virology , Lymphocytes, Tumor-Infiltrating/pathology , Papillomaviridae/isolation & purification , Papillomavirus Infections/virology , Tumor Microenvironment/immunology , Uterine Cervical Neoplasms/virology , Adult , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Female , Humans , Immunocompromised Host , Middle Aged , Neoplasm Staging , Papillomavirus Infections/mortality , Papillomavirus Infections/pathology , Prognosis , Survival Rate , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/pathology , Viral Load
4.
Appl Microbiol Biotechnol ; 103(18): 7481-7490, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31300853

ABSTRACT

Cutaneous leishmaniasis being a neglected tropical disease (NTD) faces several challenges in chemotherapy. If infected with secondary bacterial infections, the treatment regime of cutaneous ulcers in cutaneous leishmaniasis is further complicated which usually require two or more than two chemotherapeutic agents for healing. In the current study, seven curcumin-loaded self-emulsifying drug delivery system (cu-SEDDS) formulations (namely F1-F7) were prepared by mixing different excipients (oils, surfactants, and co-solvents) through stirring (vortex) and sonication. The formulations were characterized regarding their droplet size, polydispersity index (PDI), and zeta potential by zeta sizer. The cu-SEDDS formulations displayed different sizes ranging from 32.4 up to 80.0 nm. The zeta potential of the formulations ranged from - 1.56 up to - 4.8. The antileishmanial activities of the cu-SEDDS formulations in terms of IC50 against Leishmania tropica ranged from 0.19 up to 0.37 µg/ml. The minimum inhibitory concentrations (MICs) of these formulations against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumoniae were in the range of 48-62 µg/ml. The hemolysis caused by formulations was 1-2%. The spreading potential of the formulations (F1 and F5) over damaged skin model was remarkable. These results suggest that cu-SEDDS further enhanced the broad spectrum antileishmanial and antibacterial profile of curcumin and could be used for the treatment of cutaneous leishmaniasis and its associated secondary infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Infections/drug therapy , Coinfection/drug therapy , Curcumin/therapeutic use , Emulsions/chemistry , Leishmaniasis, Cutaneous/microbiology , Bacteria/drug effects , Bacteria/pathogenicity , Bacterial Infections/parasitology , Chemistry, Pharmaceutical , Coinfection/microbiology , Drug Compounding , Drug Delivery Systems , Emulsions/therapeutic use , Excipients , Humans , Leishmaniasis, Cutaneous/complications , Microbial Sensitivity Tests , Particle Size , Pseudomonas aeruginosa/drug effects , Solubility , Staphylococcus aureus/drug effects
5.
Pathol Res Pract ; 212(12): 1151-1156, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27688086

ABSTRACT

BACKGROUND AND AIMS: The causative role of high risk human papillomavirus (HR-HPV) in breast cancer development is controversial, though a number of reports have identified HR-HPV DNA in breast cancer specimens. Nevertheless, most studies to date have focused primarily on viral DNA rather than the viral transcription. The aim of this study was to investigate the presence of HR-HPV in breast cancer tissues at HPV DNA level and HPV oncogenes mRNA level by in situ hybridization (ISH). METHODS: One hundred and forty six (146) cases of breast invasive ductal carcinoma(IDC) and 83 cases of benign breast lesions were included in the study. Type specific oligonucleotide probes were used for the DNA detection of HPV 16,18 and 58 by ISH. HR-HPV oncogenes mRNA was assayed by novel RNAscope HR-HPV HR7 assay ISH. p16 protein expression was evaluated by immunohistochemistry (IHC). RESULTS: HR-HPV 16,18 and 58 DNA were detected in 52 out of 146 (35.6%) IDC and in 3 out of 83 (3.6%) benign breast lesions by ISH. The HR-HPV mRNAs was detected only in a few specimens with strong HPV DNA positivity(4/25) in a few scattered cancer cells with very weak punctate nuclear and/or cytoplasmic staining. p16 over-expression did not correlate with the HPV DNA positive breast cancer samples(17/52 HPVDNA+ vs 28/94 HPV DNA-, p=0.731). CONCLUSIONS: HR-HPVs certainly exist in breast cancer tissue with less active transcription, which implies that the causal role of HPV in breast cancer development need further study.


Subject(s)
Breast Neoplasms/virology , Carcinoma, Ductal, Breast/virology , DNA, Viral/genetics , Oncogenes/genetics , Papillomaviridae/genetics , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/genetics , Carcinoma, Ductal, Breast/pathology , Female , Human Papillomavirus DNA Tests , Humans , Middle Aged , Papillomavirus Infections/virology
6.
Pathol Res Pract ; 212(9): 804-10, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27461827

ABSTRACT

PURPOSE: High-risk human papillomavirus (HR-HPV) infections were the causal factor in the development of cervical cancer, but the significance of HPV viral load in the prediction of the response to current therapeutic approaches had not reached consensus. The present study was performed to assess the high risk HPV viral load of cervical cancer patients who underwent radiotherapy alone or in combination with chemotherapy or hyperthermotherapy or both in correlation to long-term survival. METHODS: 116 cervical cancer patients were recruited and assigned into four groups of different therapeutic modalities. The prevalent high risk types of HPV 16, 18, 58 were detected by type specific in situ hybridization (ISH), and HPV mRNA was detected by RNA scope assay using RNA scope 2.0 FFPE Reagent Kit. Semi-quantification of the HR-HPV viral load was measured based on the intensity of ISH signal captured from the tumor nests in the grey scale. RESULTS: The HR-HPV viral load had a significant negative correlation with survival (rs=-0.368, P=0.001). The 15-year survival rate of low viral load group was 68.18%, moderate viral load group was 52.17%, and high viral load group was 34.69% (P=0.001). HPV mRNA expression was strongly consistent with HPV viral load. The 15-year survival rates of different therapeutic groups were 39.29%, 58.62%, 50.00%, 55.17%, respectively (P=0.545). Combinatorial treatment modalities improved the actual survival, which demonstrated no significant difference among 5, 10 and 15 years comparison. Cox regression analysis showed that the relative risk of death was obviously higher in the HPV 18 single positive group and high HPV viral load group. CONCLUSIONS: The semi-quantitive viral load assessment in situ is a feasible approach in clinical practice. The more the HPV viral load was, the worse the survival of patients would be. The combinational treatments were in favor of the disease-stabilization.


Subject(s)
Papillomaviridae/isolation & purification , Uterine Cervical Neoplasms/therapy , Uterine Cervical Neoplasms/virology , Viral Load , Aged , Antineoplastic Agents/therapeutic use , Combined Modality Therapy , Female , Humans , Middle Aged , Prognosis , Radiotherapy , Survival Rate , Treatment Outcome , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/pathology
7.
J Coll Physicians Surg Pak ; 26(6): 541-2, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27353999

ABSTRACT

The objective of the study was to determine the diagnostic accuracy of anti-EMA antibody in comparison to histopathological findings in patients suspected of CD. This cross-sectional study was conducted at Gastroenterology Department, Fatima Memorial Hospital, Lahore, from March to October 2014. One hundred and twenty-one patients aged between 5 - 60 years of either gender were recruited in the study. Every patient went through serological testing and biopsy specimens were obtained from second part of the duodenum. Histopathological evaluation was done according to the Modified Marsh classification. The overall sensitivity of anti-EMAcame out to be 85.7% which varied with the histological lesions being 75.0%, 83.3%, and 100% for Marsh IIIA, IIIB and IIIC, respectively. Although anti-EMAhas high sensitivity but serological tests as a sole mean of diagnosis are currently unable to replace the biopsy.


Subject(s)
Antibodies/blood , Autoantibodies/blood , Celiac Disease/diagnosis , Duodenum/pathology , Mass Screening/methods , Serologic Tests/methods , Adult , Autoantibodies/analysis , Celiac Disease/blood , Celiac Disease/epidemiology , Cross-Sectional Studies , Female , Humans , Incidence , Male , Middle Aged , Pakistan/epidemiology , Predictive Value of Tests , Sensitivity and Specificity
8.
Environ Toxicol Pharmacol ; 43: 83-93, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26970059

ABSTRACT

Mitochondrial dysfunction has recently received considerable attention as it plays an important role in adult human pathology caused by various drugs, endogenous agents and environmental agents. Benzo(a)pyrene (BaP), is a ubiquitous environmental contaminant mainly derived from anthropogenic activity during incomplete combustion of organic materials from various sources. The present study aimed to evaluate the effects of benzo(a)pyrene (BaP) on mitochondrial enzymes in the multiple organs including liver, lung, brain, stomach and kidney. ICR mice were exposed to different doses of BaP (2.5, 5 and 10mg/kg body weight) through oral gavage and intraperitoneal injection treatment for 13 weeks consecutively. The induced mitochondrial damage in the examined organs was assayed in terms of significant increase in lipid peroxidation (LPO) and prominent decrease in antioxidant enzymes. Non enzymatic antioxidants and Krebs cycle's enzymes were also significantly decreased in mitochondria. Additionally, BaP induced the body growth retardation and decrease in relative liver weight, increase in relative lung, stomach, kidney and brain weights, and this was further certified through histopathological lesions. Liver and lungs were more prominently damaged by BaP. The mitochondrial depletion increased in BaP dose-dependent manner.


Subject(s)
Benzo(a)pyrene/toxicity , Hazardous Substances/toxicity , Mitochondria/enzymology , Animals , Humans , Kidney/enzymology , Liver/enzymology , Lung/enzymology , Mice , Mice, Inbred ICR , Mitochondria/drug effects , Stomach/enzymology , Toxicity Tests
9.
Acta Histochem ; 118(2): 63-73, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26709117

ABSTRACT

Epidemiological studies have demonstrated that cigarette smoking is an important cofactor or an independent risk factor for the development of cervical cancer. Benzo(a)pyrene (BaP) is one of the most potent tobacco smoke carcinogens in tobacco smoke. BaP induced DNA damage and over expression in p53 cervical tissue of mice as demonstrated in our previous study. Here we present the findings of exposure to BaP on the expression of Bcl-2, C-myc, Ki-67, Caspase-3 and Bax genes in mouse cervix. Acute intraperitoneal administration of BaP (12.5, 25, 50, 100mg/kg body weight) to ICR female mice induced a significant increase in Bcl-2, C-myc, Ki-67 mRNA and protein level till 72h except in Bcl-2 at 24h with 12.5, 25, 50mg/kg as well as at 48h with 12.5mg/kg body weight post treatment. A significant increase was also seen in Caspase-3 and Bax mRNA and protein level with peak level at 24h and gradual decrease till 72h, however, the expression of caspase-3 increased while that of Bax decreased with increasing dose of Bap after 24h. In sub chronic intraperitoneal and oral gavage administration of BaP (2.5, 5, 10mg/kg body weight), similar significant increase was observed for all the examined genes as compared to the control and vehicle groups, however the expression of Bax decreased in a dose dependent manner. The findings of this study will help in further understanding the molecular mechanism of BaP induced carcinogenesis of cervical cancer.


Subject(s)
Benzo(a)pyrene/toxicity , Carcinogens/toxicity , Caspase 3/metabolism , Cervix Uteri/metabolism , Ki-67 Antigen/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Animals , Carcinogenesis/metabolism , Cervix Uteri/drug effects , Cervix Uteri/pathology , Female , Gene Expression/drug effects , Mice, Inbred ICR , RNA, Messenger/genetics , RNA, Messenger/metabolism , Smoking/adverse effects , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/metabolism
10.
J Coll Physicians Surg Pak ; 25(6): 422-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26100994

ABSTRACT

OBJECTIVE: To determine the accuracy of Fine Needle Aspiration Cytology (FNAC) in the diagnosis of tuberculous lymphadenitis. STUDY DESIGN: Comparative cross-sectional study. PLACE AND DURATION OF STUDY: Department of Pathology, Khalifa Gul Nawaz Teaching Hospital (KGNTH), Bannu, from September 2012 to March 2013. METHODOLOGY: FNAC of enlarged lymph nodes was performed in the Department of Pathology, KGNTH, Bannu. Smears of the aspirates were examined under light microscope after staining with Haematoxylin and Eosin (H & E) stains. In cases of chronic lymphadenitis, the smears were stained with Ziehl-Neelsen (ZN) stain for Acid Fast Bacilli (AFB). If no AFB was visualized, the aspirate was subjected to culture on Lowenstein Jensen (LJ) medium for yield of AFB. The results were analyzed by Microsoft Excel software. RESULTS: Chronic granulomatous lymphadenitis was found in 110 (46.81%) out of 235 cases. AFB were seen in aspirates of 43/110 (39.09%) cases by direct microscopy. Among the remaining 67 aspirates subjected to LJ medium, only 07 (10.45%) yielded growth of AFB. Smears of 4/15 (3.6%), 13/47 (11.7%) and 33/48 (29.7%) cases with haemorrhagic, inflammatory and caseous background respectively, were confirmed by conventional microbiologic tests. Out of 125 nongranulomatous lymphadenitis cases only 05 were confirmed to be due to tuberculosis by direct microscopy while culture was not positive in any case. Thus accuracy of FNAC was 72.34%. CONCLUSION: FNAC has a good accuracy in diagnosing tuberculous lymphadenopathy.


Subject(s)
Biopsy, Fine-Needle/methods , Lymph Nodes/pathology , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Lymph Node/pathology , Adolescent , Adult , Aged , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Lymph Nodes/microbiology , Male , Middle Aged , Reproducibility of Results , Staining and Labeling/methods , Tuberculosis, Lymph Node/microbiology , Young Adult
11.
Asian Pac J Cancer Prev ; 16(2): 579-83, 2015.
Article in English | MEDLINE | ID: mdl-25684490

ABSTRACT

This study was conducted on female patients with different gynecological problems attending the gynecology out-patient departments of two tertiary care hospitals in Peshawar city of Khyber Pakhtunkhwa, Pakistan between August 2012 and October 2013. The 200 patients had an age range of 21-65 years. Smears were taken with cervical brushes and preserved in preservative medium and processed for manual liquid based cytology (MLBC) for Pap staining. Out of 200 collected samples, 30 samples were found inadequate on cytology. Of the remaining 170 samples, 164 (96.47%) were normal, 5 (2.94%) were of atypical squamous cells of unknown significance (ASCUS) and 1 (0.6%) was of high grade squamous intraepithelial lesion (HSIL). On PCR all the samples were positive for beta globin gene fragment including those reported inadequate on cytology. Out of the 5 ASCUS samples, 2 samples were positive for HPV, one each for HPV 16 and HPV 18, and the rest of the 3 samples were negative for HPV DNA. The 1 sample of HSIL was positive for HPV 16 on PCR. Out of 164 normal samples on cytology, only 1 sample was HPV 16 positive. So overall, 4 (2%) out of 200 samples were positive for HPV DNA, where 3 were HPV 16 (1.5%), and 1 was HPV 18 (0.5%) positive, and thus the ratio of infection with of HPV 16 to HPV 18 was 3:1 in the general population. In conclusion, PCR based HPV detection is a more sensitive method for screening of HPV infection than cytology as sample inadequacy does not affect the results. However, it can be combined with cytology methods in a HPV positive female to achieve the maximum results.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Cytodiagnosis , Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Specimen Handling/methods , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Neoplasms/diagnosis , Adult , Aged , Biopsy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , DNA, Viral/genetics , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Staging , Pakistan , Papanicolaou Test , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Polymerase Chain Reaction , Prognosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Young Adult , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/virology
12.
J Med Virol ; 87(6): 1034-40, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25676062

ABSTRACT

A number of reports have identified HPV DNA in breast cancer specimens and HPV type 16, 18, 31, 33, 45, and 51 were more prevalent. HPV 58 was frequently detected in cervical cancer in Shaanxi China. The aim of the present study was to investigate whether HPV 58 present in breast cancer. 169 cases of breast cancer samples and 83 benign breast lesions were analyzed. Type specific primers and oligonucliotide probe were used for the detection of HPV 58 by conventional PCR and in situ hybridization techniques. The HPV 58 viral load were measured by qPCR. p16 protein expression were evaluated by immunohistochemistry. HPV 58 E7 DNA was detected in 25 out of 169 formalin fixed paraffin embedded breast cancer tissues (14.79%) by PCR, only 1 out of 83 non-malignant breast lesions showed positive (1.20%). The results of ISH showed that 17 out of 169 (10.06%) malignant samples were positive for HPV 58 E7, and only 1 out of 83 non-malignant lesions was positive. Positive p16 immunostaining was observed in all the HPV 58 E7 ISH positive cases, but 16 out of 98 cases with HPV negative were p16 positive. The presence of HPV 58 in both normal duct epithelial cells and carcinoma in situ along with its presence in the cancer cells of the same specimen indicated the possible causal role of HPV 58 in breast cancer. The findings provide a solid morphological evidence of the involvement of HPV 58 in breast cancer development.


Subject(s)
Alphapapillomavirus/isolation & purification , Carcinoma, Ductal, Breast/virology , DNA, Viral/isolation & purification , Papillomavirus Infections/virology , Adult , Aged , Alphapapillomavirus/genetics , Carcinoma in Situ/virology , Carcinoma, Squamous Cell/virology , China , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , DNA Primers , Female , Human papillomavirus 16/genetics , Humans , In Situ Hybridization , Middle Aged , Uterine Cervical Neoplasms/virology , Viral Load
13.
Asian Pac J Cancer Prev ; 15(17): 7105-12, 2014.
Article in English | MEDLINE | ID: mdl-25227798

ABSTRACT

In this study, we investigated oxidative stress and tumor marker levels of polycyclic aromatic hydrocarbons (PAHs) in 136 coke oven workers and in 60 control subjects, and evaluated the correlation between oxidative stress and tumor marker levels. Questionnaires on basic demographic information were also administered. Significant differences in employment time and percentages of alcohol drinkers were observed between the control and exposed groups. PAH exposure was assessed using urinary 1-hydroxy-pyrene (1-OHP) levels and was found to be significantly higher in workers than in the controls. Significant differences (P<0.001) of MDA, GST, LDH, NSE, Cyfra21-1, and of SCC and TNF-a (P<0.0001 and P<0.05, P<0.001, respectively) levels were observed among controls and coke-oven workers, except for bottom coke oven workers. Associations between age and risk of increased TNF-a, smoking and increased GST activities, and drinking with increased MDA concentrations, were marginal (P=0.055, P=0.048, P=0.057, respectively). The association between smoking with MDA (P=0.004), NSE (P=0.005), SCC (P=0.004) and TNF-a (P<0.001), and drinking with TNF-a levels was significant (P=0.012). In addition, a significant positive correlation between oxidative stress and tumor markers was found in the present study. These results suggest that a synergistic increase of oxidative stress and tumor markers induced by PAHs may play a role in toxic responses for PAHs in coke oven workers.


Subject(s)
Biomarkers, Tumor/blood , Manufacturing Industry , Occupational Exposure , Oxidative Stress , Polycyclic Aromatic Hydrocarbons , Adult , Alcohol Drinking/blood , Antigens, Neoplasm/blood , Biomarkers, Tumor/urine , Case-Control Studies , Coke , Glutathione Transferase/blood , Humans , Keratin-19/blood , L-Lactate Dehydrogenase/blood , Male , Malondialdehyde/blood , Phosphopyruvate Hydratase/blood , Pyrenes/urine , Serpins/blood , Smoking/blood , Tumor Necrosis Factor-alpha/blood
14.
Asian Pac J Cancer Prev ; 15(6): 2699-705, 2014.
Article in English | MEDLINE | ID: mdl-24761888

ABSTRACT

This study was to undertaken to investigate the impacts of AhR, CYP1A1, GSTM1 genetic polymorphisms on the R273G mutation in exon 8 of the tumor suppressor p53 gene (TP53) among polycyclic aromatic hydrocarbons (PAHs) exposed to coke-oven workers. One hundred thirteen workers exposed to PAH and 82 control workers were recruited. We genotyped for polymorphisms in the AhR, CYP1A1, GSTM1, and TP53 R273G mutation in blood by PCR methods, and determined the levels of 1-hydroxypyrene as PAH exposure marker in urine using the high pressure liquid chromatography assay. We found that the distribution of alcohol users and the urinary excretion of 1-OHP in the exposed workers were significantly higher than that of the control workers (p=0.004, p<0.001, respectively). Significant differences were observed in the p53 genotype distributions of smoking subjects (p=0.01, 95%CI: 1.23-6.01) and PAH exposure (p=0.008, 95%CI: 1.24-4.48), respectively. Further, significant differences were observed in the p53 exon 8 mutations for the genetic polymorphisms of Lys/Arg for AhR (p=0.02, 95%CI: 0.70-15.86), Val/Val for CYP1A1 (p=0.04, 95%CI: 0.98-19.09) and null for GSTM1 (p=0.02, 95%CI: 1.19-6.26), respectively. Our findings indicated that polymorphisms of PAH metabolic genes, such as AhR, CYP1A1, GSTM1 polymorphisms may interact with p53 genetic variants and may contribute to PAH related cancers.


Subject(s)
Aromatase/genetics , Basic Helix-Loop-Helix Transcription Factors/genetics , Glutathione Transferase/genetics , Mutation/genetics , Occupational Diseases/urine , Occupational Exposure/adverse effects , Polycyclic Aromatic Hydrocarbons/adverse effects , Polymorphism, Genetic/genetics , Receptors, Aryl Hydrocarbon/genetics , Tumor Suppressor Protein p53/genetics , Adult , Case-Control Studies , Chromatography, High Pressure Liquid , DNA Damage/genetics , Follow-Up Studies , Genotype , Humans , Male , Occupational Diseases/chemically induced , Occupational Diseases/genetics , Prognosis
15.
Asian Pac J Cancer Prev ; 15(2): 975-81, 2014.
Article in English | MEDLINE | ID: mdl-24568528

ABSTRACT

Cervical cancer is an issue of foremost importance globally, specifically affecting the developing nations. Significant advances have taken place with regard to diagnosis of cervical cancer, especially with screening. Appropriate screening measures can thus reduce the incidence of cervical cancer. The most desirable screening technique should be less invasive, easy to perform, cost-effective and cover a wide range of diagnostic icons. Manual liquid based cytology (MLBC) can be considered as one of the suitable technique for screening with the above-mentioned benefits. The aim of the current study was to compare two cervical screening techniques on the basis of different morphological parameters and staining parameters by using modified acetic acid Pap staining to see the possibility of reducing time economy involved in conventional Pap staining (CPS). The study was conducted on a total 88 cases and all were analyzed with both MLBC and CPS. Forty eight cases that were regarded as satisfactory on the basis of Bethesda system by both methods were further recruited for investigation. Their morphological parameters and staining quality were compared and scored according to a scoring system defined in the study. Quality indices was calculated for both staining procedures and smear techniques.


Subject(s)
Cervix Uteri/pathology , Cytological Techniques/methods , Early Detection of Cancer , Precancerous Conditions/diagnosis , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears , Female , Follow-Up Studies , Humans , Papanicolaou Test , Precancerous Conditions/prevention & control , Prognosis , Uterine Cervical Neoplasms/prevention & control
16.
Radiat Res ; 179(5): 584-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23510275

ABSTRACT

Local radiotherapy is the major therapeutic approach to control inoperable cervical cancer. In this study, we analyzed the local immune microenvironment of cervical cancer before and after clinical radiation therapy to investigate whether tumor response due to immunomodulation. A total of 59 patients with pathologically diagnosed cervical cancers classified according to the International Federation of Obstetrics and Gynecology (FIGO) criteria were recruited. The patients were treated according to their disease status with standard radiation regimens. For each patient, tumor biopsies were conducted before, during and after radiation treatment with the doses of 0, 10, 20 and 30 Gy, respectively. All of the tumor samples were then grouped according to the doses delivered and tumor infiltrating lymphocytes with the biomarkers of CD8, CD4, FOXP3 and OX40 were measured by in situ immunohistochemistry. We found that before radiation treatment both CD8(+) T cell and CD4(+) T cell infiltrates were more present in the tumor stroma than in the tumor nests, while OX40(+) and FOXP3(+) T cell infiltrates were present at similar levels in both the tumor nests and stroma. After radiation treatment, the levels of CD8(+) T cells and CD4(+) T cells in the tumor nests and stroma were decreased compared with the levels before irradiation. However, OX40(+) T cells and FOXP3(+) T cells did not show any difference before and after irradiation, which indicates that the FOXP3(+) T cells were more resistant to ionizing radiation than were the cytotoxic effector T cells and demonstrates a dynamic rebalance of infiltrating lymphocytes in the tumor milieu occurs after radiotherapy. This suggest that local antitumor immunity could be compromised due to decreased cytotoxic effector cells and the relatively stable status of FOXP3(+) T cells after irradiation. Therefore, regulation of these FOXP3(+) T cells may be a potentially effective approach to enhance the efficacy of cancer radiation therapy.


Subject(s)
T-Lymphocytes, Cytotoxic/radiation effects , T-Lymphocytes, Regulatory/radiation effects , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/radiotherapy , Adult , Aged , Female , Forkhead Transcription Factors/metabolism , Humans , Middle Aged , Receptors, OX40/metabolism , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Tumor Microenvironment/radiation effects , Uterine Cervical Neoplasms/pathology
17.
Diagn Pathol ; 7: 157, 2012 Nov 17.
Article in English | MEDLINE | ID: mdl-23157817

ABSTRACT

Hydatid disease, a parasitic infection is caused by Echinococcus granulosus. It has serious impact on health and economy especially in countries where it is endemic. It occurs frequently in liver and lung. The disease is chronic and cyst can localize in different organs. A hydatid cyst occurrence in the head and neck is extremely rare. To know the distribution of disease can help in its control and prevention. We report a case of primary cervical hydatid cyst in 20 year old female. A high index of suspicion is required to diagnose hydatid cyst in rare locations like this. Hydatid cyst should be considered in differential diagnosis of benign swellings of head and neck region, so that it can be managed during surgery to prevent acute anaphylaxis. VIRTUAL SLIDES: The virtual slides' for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4915595218376646.


Subject(s)
Echinococcosis/diagnosis , Albendazole/therapeutic use , Anticestodal Agents/therapeutic use , Biopsy , Diagnosis, Differential , Echinococcosis/therapy , Female , Humans , Magnetic Resonance Imaging , Neck , Predictive Value of Tests , Treatment Outcome , Young Adult
18.
Basic Clin Pharmacol Toxicol ; 109(5): 398-406, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21733121

ABSTRACT

Benzo[a]pyrene (BaP) is a representative compound of polycyclic aromatic hydrocarbons exerting cytotoxicity and genotoxicity in the human liver, lung, stomach and skin. However, the toxic effect of BaP on cervical tissue remains unclear. This study was carried out to investigate the toxic effects of BaP on the cervix of ICR mice. Female mice were treated with BaP by intraperitoneal injection and oral gavage at a dose of 2.5, 5 and 10 mg/kg body-weight, twice a week for 14 weeks. BaP treatment caused a significant increase in the levels of MDA and IL-6 with significantly increased activity of CYP1A1, creatine kinase and aspartate aminotransferase (AST) and decreased activity of glutathione-S-transferase in the cervix and liver. The relative cervix weight was markedly reduced in the intraperitoneal BaP injection groups, whereas only a slight reduction was observed in the oral gavage groups. The increase in weight decreased with increasing BaP dose. Moreover, BaP treatment induced significant pathomorphological changes in the cervical tissue and increased the mortality of the mice. Taken together, these results suggest that BaP causes a certain toxic effect on cervical tissue.


Subject(s)
Benzo(a)pyrene/toxicity , Cervix Uteri/drug effects , Cervix Uteri/pathology , Animals , Aspartate Aminotransferases/metabolism , Biomarkers , Body Weight/drug effects , Creatine Kinase/metabolism , Cytochrome P-450 CYP1A1/metabolism , Female , Glutathione Transferase/metabolism , Injections, Intraperitoneal , Interleukin-6/analysis , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Malondialdehyde/analysis , Mice , Mice, Inbred ICR
19.
Cell Mol Immunol ; 8(1): 59-66, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21200385

ABSTRACT

In this study, 40 biopsy samples collected from cervical cancer patients at the First Affiliated Hospital of Xi'an Jiaotong University, China, were retrospectively assessed using immunohistochemistry for CD4(+) and CD8(+) tumor-infiltrating lymphocytes (TILs) and were analyzed for the expression of FOXP3, OX40, granzyme B (GrB) and perforin (Prf). The proliferating index of the TILs was determined by assessing Ki67 expression. We determined the prognostic value of low and high numbers of TILs on survival by performing Kaplan-Meier analysis using median values as the cut-off points. Except for the number of CD4(+)FOXP3(+) regulatory T cells (Tregs) and the CD4/CD8 ratio, none of the CD4(+), CD8(+), OX40(+), GrB(+) or Prf(+) TILs were associated with the overall 5-year survival rate. The 5-year survival rate was significantly lower in patients who had a high percentage of Tregs as compared with the those who had a lower percentage (35.3% versus 88.9%, P=0.001), while the 5-year survival rate was significantly higher in patients with a high CD4/CD8 ratio as compared with patients who had a low CD4/CD8 ratio (82.4% versus 44.4%, P=0.029). When we considered the deaths and surviving cases as separate groups, we found that both the number of CD4(+) T cells and the CD4/CD8 ratio were significantly lower in patients who died as compared with those who survived (26.33±11.80 versus 47.79±38.18, P=0.023 and 0.60±0.25 versus 1.17±1.02, P=0.019, respectively). In conclusion, decreased proportions of tumor-infiltrating CD4(+) T cells with high percentages of Tregs and reversed CD4/CD8 ratios were significantly associated with the clinical outcome of patients with cervical carcinoma.


Subject(s)
CD4-CD8 Ratio , Carcinoma, Squamous Cell , Lymphocytes, Tumor-Infiltrating , T-Lymphocytes, Regulatory , Adult , Aged , Antigens, Differentiation, T-Lymphocyte/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Cervix Uteri/immunology , Cervix Uteri/pathology , Female , Humans , Kaplan-Meier Estimate , Lymphocyte Count/trends , Lymphocytes, Tumor-Infiltrating/immunology , Lymphocytes, Tumor-Infiltrating/pathology , Middle Aged , Prognosis , Retrospective Studies , Survival Rate , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/pathology
20.
Mutat Res ; 719(1-2): 52-9, 2011 Feb 03.
Article in English | MEDLINE | ID: mdl-21115130

ABSTRACT

Benzo[a]pyrene [B(a)P] is one of the most prevalent environmental carcinogens and genotoxic agents. However, the mechanisms of B(a)P-induced oxidative damage in cervical tissue are still not clear. The present study was to investigate the oxidative stress and DNA damage in cervix of ICR female mice induced by acute treatment with B(a)P. Oxidative stress was assayed by analysis of malondialdehyde (MDA), superoxide anion and H(2)O(2), and antioxidant enzymes. The alkaline single-cell electrophoresis (SCGE) was used to measure DNA damage. The contents of MDA and glutathione (GSH), and the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione S-transferase (GST) were significantly increased in cervix 24, 48 and 72h after B(a)P treatment of a single dose of 12.5 and 25mg/kg, while GSH, CAT, SOD and GST had no significant difference with the dose of 50mg/kg B(a)P at post-treatment time 48 and 72h except for SOD activity at 48h which was significant. The maximum values of SOD, CAT, GST and GSH were peaked at 24h and then decreased gradually while GPx activities and MDA levels persisted for up to 72h. Superoxide anion, H(2)O(2) and DNA damage changed similarly as the activity of SOD, CAT or GST. Additionally, increases of formamidopyrimidine DNA glycosylase (FPG) specific DNA damage were observed and can be greatly rescued by vitamin C pretreatment. Overall, B(a)P demonstrated a time- and dose- related oxidative stress and DNA damage in cervix.


Subject(s)
Benzo(a)pyrene/toxicity , Cervix Uteri/drug effects , DNA Damage , Oxidative Stress/drug effects , Animals , Catalase/metabolism , Cells, Cultured , Cervix Uteri/cytology , Cervix Uteri/metabolism , Comet Assay/methods , DNA-Formamidopyrimidine Glycosylase/metabolism , Dose-Response Relationship, Drug , Female , Glutathione Peroxidase/metabolism , Glutathione Transferase/metabolism , Malondialdehyde/metabolism , Mice , Mice, Inbred ICR , Superoxide Dismutase/metabolism , Superoxides/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...